Compare Stocks: UFPT, BLCO, MMSI, and NVST

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLCO Bausch + Lomb	$17.77 -1.5%	$16.90	$13.77 ▼ $18.92	$6.44B	0.56	383,980 shs	335,604 shs
MMSI Merit Medical Systems	$87.38 -2.5%	$82.60	$59.74 ▼ $94.75	$5.35B	0.49	675,913 shs	1.42 million shs
NVST Envista	$26.81 -1.7%	$27.24	$18.77 ▼ $30.42	$4.38B	0.86	2.05 million shs	2.48 million shs
UFPT UFP Technologies	$281.21 -2.6%	$280.78	$173.86 ▼ $338.71	$2.24B	1.08	122,323 shs	115,619 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLCO Bausch + Lomb	-1.47%	-0.64%	+6.15%	+16.62%	+14.58%
MMSI Merit Medical Systems	-2.48%	-3.64%	-1.86%	+30.44%	-5.36%
NVST Envista	-1.15%	+0.55%	-5.00%	+11.45%	+26.84%
UFPT UFP Technologies	-2.62%	-4.37%	-10.45%	+20.96%	+36.65%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLCO Bausch + Lomb	$17.77 -1.5%	$16.90	$13.77 ▼ $18.92	$6.44B	0.56	383,980 shs	335,604 shs
MMSI Merit Medical Systems	$87.38 -2.5%	$82.60	$59.74 ▼ $94.75	$5.35B	0.49	675,913 shs	1.42 million shs
NVST Envista	$26.81 -1.7%	$27.24	$18.77 ▼ $30.42	$4.38B	0.86	2.05 million shs	2.48 million shs
UFPT UFP Technologies	$281.21 -2.6%	$280.78	$173.86 ▼ $338.71	$2.24B	1.08	122,323 shs	115,619 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLCO Bausch + Lomb	-1.47%	-0.64%	+6.15%	+16.62%	+14.58%
MMSI Merit Medical Systems	-2.48%	-3.64%	-1.86%	+30.44%	-5.36%
NVST Envista	-1.15%	+0.55%	-5.00%	+11.45%	+26.84%
UFPT UFP Technologies	-2.62%	-4.37%	-10.45%	+20.96%	+36.65%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLCO Bausch + Lomb	2.31	Hold	$18.75	5.54% Upside
MMSI Merit Medical Systems	2.83	Moderate Buy	$100.00	14.44% Upside
NVST Envista	2.56	Moderate Buy	$29.71	10.85% Upside
UFPT UFP Technologies	2.00	Hold	N/A	N/A

Current Analyst Ratings Breakdown

Latest UFPT, BLCO, MMSI, and NVST Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/3/2026	NVST Envista	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$32.00
9/3/2026	NVST Envista	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$29.00 ➝ $32.00
8/28/2026	BLCO Bausch + Lomb	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$21.00
8/25/2026	MMSI Merit Medical Systems	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/21/2026	BLCO Bausch + Lomb	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/18/2026	MMSI Merit Medical Systems	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/13/2026	MMSI Merit Medical Systems	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$92.00 ➝ $97.00
8/11/2026	MMSI Merit Medical Systems	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$105.00
8/7/2026	BLCO Bausch + Lomb	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/7/2026	NVST Envista	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/6/2026	NVST Envista	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)

(Data available from 9/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLCO Bausch + Lomb	$5.10B	1.24	$1.64 per share	10.81	$18.40 per share	0.97
MMSI Merit Medical Systems	$1.52B	3.44	$5.73 per share	15.24	$26.72 per share	3.27
NVST Envista	$2.86B	1.51	$2.13 per share	12.56	$18.89 per share	1.42
UFPT UFP Technologies	$602.80M	3.62	$12.03 per share	23.38	$54.96 per share	5.12

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLCO Bausch + Lomb	-$360M	-$0.48	N/A	16.92	0.57	-3.21%	4.14%	1.93%	11/4/2026 (Estimated)
MMSI Merit Medical Systems	$128.49M	$2.42	36.11	20.95	2.24	9.22%	13.75%	8.10%	10/29/2026 (Estimated)
NVST Envista	$47M	$0.58	46.22	16.25	1.30	3.33%	7.88%	4.33%	11/4/2026 (Estimated)
UFPT UFP Technologies	$68.31M	$9.28	30.30	23.34	N/A	11.45%	18.42%	11.96%	11/2/2026 (Estimated)

Latest UFPT, BLCO, MMSI, and NVST Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q2 2026	NVST Envista	$0.3353	$0.41	+$0.0747	$0.33	$716.11 million	$730.50 million
8/3/2026	Q2 2026	UFPT UFP Technologies	$2.31	$2.92	+$0.61	$2.68	$159.38 million	$173.96 million
7/30/2026	Q2 2026	MMSI Merit Medical Systems	$0.9590	$1.19	+$0.2310	$0.65	$405.25 million	$418.84 million
7/29/2026	Q2 2026	BLCO Bausch + Lomb	$0.16	$0.15	-$0.01	-$0.04	$1.37 billion	$1.39 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLCO Bausch + Lomb	N/A	N/A	N/A	N/A	N/A
MMSI Merit Medical Systems	N/A	N/A	N/A	N/A	N/A
NVST Envista	N/A	N/A	N/A	N/A	N/A
UFPT UFP Technologies	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLCO Bausch + Lomb	0.79	1.55	1.02
MMSI Merit Medical Systems	0.44	4.20	2.79
NVST Envista	0.47	2.43	2.07
UFPT UFP Technologies	0.26	3.00	1.72

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BLCO Bausch + Lomb	11.07%
MMSI Merit Medical Systems	99.66%
NVST Envista	N/A
UFPT UFP Technologies	87.28%

Insider Ownership

Company	Insider Ownership
BLCO Bausch + Lomb	1.45%
MMSI Merit Medical Systems	0.70%
NVST Envista	0.99%
UFPT UFP Technologies	4.59%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BLCO Bausch + Lomb	13,000	357.17 million	351.99 million	Optionable
MMSI Merit Medical Systems	7,500	59.71 million	59.29 million	Optionable
NVST Envista	12,000	160.62 million	159.03 million	Optionable
UFPT UFP Technologies	5,349	7.75 million	7.39 million	Optionable

UFPT, BLCO, MMSI, and NVST Headlines

Recent News About These Companies

UFP Technologies, Inc. (NasdaqCM:UFPT) a acquis Creative Imprints, Inc.

September 8 at 8:48 AM | zonebourse.comZ

The Manufacturers Life Insurance Company Buys Shares of 3,732 UFP Technologies, Inc. $UFPT

September 6 at 4:24 AM | marketbeat.com

Legal & General Group Plc Invests $4.78 Million in UFP Technologies, Inc. $UFPT

September 4, 2026 | marketbeat.com

UFP Technologies (UFPT) Posts Record Profits, But The Margin Story Gets Complicated

September 3, 2026 | insidermonkey.com

Bank of New York Mellon Corp Acquires New Holdings in UFP Technologies, Inc. $UFPT

September 2, 2026 | marketbeat.com

UFP Technologies Director Cynthia Feldmann Sells 1,000 Shares

August 31, 2026 | fool.com

UFP Technologies Targets 12%-18% Growth as Medical Device M&A Pipeline Builds

August 28, 2026 | marketbeat.com

Insider Selling: UFP Technologies (NASDAQ:UFPT) Director Sells 7,000 Shares

August 28, 2026 | insidertrades.com

Deutsche Bank AG Makes New Investment in UFP Technologies, Inc. $UFPT

August 28, 2026 | marketbeat.com

UFP Technologies (NASDAQ:UFPT) Director Marc Kozin Sells 7,000 Shares

August 27, 2026 | marketbeat.com

Punch & Associates Investment Management Inc. Takes Position in UFP Technologies, Inc. $UFPT

August 27, 2026 | marketbeat.com

EFG International AG Acquires Shares of 15,000 UFP Technologies, Inc. $UFPT

August 27, 2026 | marketbeat.com

BlackRock Inc. Buys New Position in UFP Technologies, Inc. $UFPT

August 27, 2026 | marketbeat.com

UFP Industries: A Good Name To Follow, But A Bit Expensive Right Now

August 25, 2026 | seekingalpha.com

UFP Technologies Submits Updated Investor Presentation in Compliance with Regulation FD

August 24, 2026 | kalkinemedia.comK

UFP Technologies Updates Investor Presentation and Strategic Outlook

August 24, 2026 | tipranks.com

36,030 Shares in UFP Technologies, Inc. $UFPT Purchased by Ranger Investment Management L.P.

August 24, 2026 | marketbeat.com

Neumeier Poma Investment Counsel LLC Takes $22.42 Billion Position in UFP Technologies, Inc. $UFPT

August 24, 2026 | marketbeat.com

Bank of America Corp DE Purchases 9,404 Shares of UFP Technologies, Inc. $UFPT

August 24, 2026 | marketbeat.com

De Lisle Partners LLP Acquires Shares of 74,302 UFP Technologies, Inc. $UFPT

August 23, 2026 | marketbeat.com

7,475 Shares in UFP Technologies, Inc. $UFPT Acquired by B. Metzler seel. Sohn & Co. AG

August 23, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT, BLCO, MMSI, and NVST Company Descriptions

Bausch + Lomb NYSE:BLCO

$17.76 -0.28 (-1.52%)

Closing price 09/8/2026 03:59 PM Eastern

Extended Trading

$17.56 -0.21 (-1.18%)

As of 09/8/2026 07:33 PM Eastern

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.

Merit Medical Systems NASDAQ:MMSI

$87.38 -2.22 (-2.48%)

Closing price 09/8/2026 04:00 PM Eastern

Extended Trading

$87.40 +0.02 (+0.02%)

As of 09/8/2026 07:30 PM Eastern

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Envista NYSE:NVST

$26.81 -0.47 (-1.73%)

Closing price 09/8/2026 03:59 PM Eastern

Extended Trading

$26.90 +0.09 (+0.33%)

As of 09/8/2026 07:30 PM Eastern

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

UFP Technologies NASDAQ:UFPT

$281.21 -7.58 (-2.62%)

Closing price 09/8/2026 04:00 PM Eastern

Extended Trading

$280.83 -0.38 (-0.14%)

As of 09/8/2026 07:58 PM Eastern

UFP Technologies, Inc. designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. It also provides molded composites for commercial aviation and military gear for use in backpack components, knee and elbow pads, eyewear, and helmets; and reusable cases and custom for applications in military ballistics panels, virtual training systems, drones, communications equipment, and rugged portable computers. In addition, the company provides engineered products and components to customers in the automotive, aerospace and defense, and industrial markets for applications in military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest UFPT, BLCO, MMSI, and NVST Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest UFPT, BLCO, MMSI, and NVST Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

UFPT, BLCO, MMSI, and NVST Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT, BLCO, MMSI, and NVST Company Descriptions

Bausch + Lomb NYSE:BLCO

Merit Medical Systems NASDAQ:MMSI

Envista NYSE:NVST

UFP Technologies NASDAQ:UFPT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest UFPT, BLCO, MMSI, and NVST Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest UFPT, BLCO, MMSI, and NVST Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

UFPT, BLCO, MMSI, and NVST Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT, BLCO, MMSI, and NVST Company Descriptions

Bausch + Lomb NYSE:BLCO

Merit Medical Systems NASDAQ:MMSI

Envista NYSE:NVST

UFP Technologies NASDAQ:UFPT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools